Torrent Pharma, Reliance Life sign licence agreement for biosimilars

Mumbai: Torrent Pharmaceuticals has entered into an exclusive licensing agreement with Reliance Life Sciences for marketing three biosimilars in India — Rituximab, Adalimumab and Cetuximab.

…read more

Source:: Feed

Become a member

The NICCT informs its members about relevant business developments in India and the Netherlands. The NICCT also inspires its members by organizing various programs throughout the year and providing the opportunity for you to meet your peers and build your network. We are also influencing relevant stakeholders to optimize business relations between the Netherlands and India. By doing this we promote business and economic relations between India and the Netherlands to the mutual benefit of both countries.

News URL